A Randomized Clinical Trial of Snus Examining the Effect of Complete Versus Partial Cigarette Substitution on Smoking-Related Behaviors, and Biomarkers of Exposure.


Journal

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
ISSN: 1469-994X
Titre abrégé: Nicotine Tob Res
Pays: England
ID NLM: 9815751

Informations de publication

Date de publication:
17 04 2020
Historique:
received: 20 11 2018
accepted: 05 04 2019
pubmed: 20 7 2019
medline: 29 9 2020
entrez: 20 7 2019
Statut: ppublish

Résumé

This 8-week multisite, randomized controlled trial of snus examined the differential effects of instructions on (1) snus use, (2) smoking and smoking-related measures, and (3) exposure to tobacco-related constituents. US adult daily cigarette smokers (n = 150; 43.3% female; Medianage = 43.5) were recruited from Minneapolis, Minnesota; Columbus and Coshocton, Ohio; and Buffalo, New York. Following a 1-week sampling phase of snus, participants who used at least 7 pouches were randomized to either (1) partial substitution (PS; "use snus as you like with your cigarettes"), (2) complete substitution (CS; "avoid cigarettes"), or (3) usual brand cigarettes (UB). Analyses included between-group analyses (eg, PS vs. CS) using Wilcoxon rank sum test of cigarettes per day and snus pouches per day, and a linear mixed model (biomarkers). Compared to the PS and UB groups, smokers assigned to CS reported greater reductions in cigarettes per day (ps < .001), using more snus pouches per day (p = .02), and more smoke-free days (CS median = 14.5, PS and UB medians = 0, p < .001). In addition, results demonstrated reductions in carbon monoxide (p < .001), total nicotine equivalents (p = .02), and four out of five measured volatile organic compounds (ps < .01) over time among the CS group. Exposure to N'-nitrosonornicotine increased by trial end only among the PS group (p < .04). Phenanthrene tetraol increased among all groups by trial end (p = .02) with no difference between groups. Instructions to completely switch from cigarettes to snus resulted in the greatest reduction in cigarettes and exposure to harmful constituents. Directly instructing smokers to switch completely to snus, rather than using ad libitum (with no instructions to avoid cigarettes), is necessary for reductions in smoking and subsequent exposure to harmful constituents.

Identifiants

pubmed: 31321423
pii: 5445258
doi: 10.1093/ntr/ntz055
pmc: PMC7164575
doi:

Substances chimiques

Biomarkers 0
Nitrosamines 0
Carbon Monoxide 7U1EE4V452
N'-nitrosonornicotine X656TZ86DX

Types de publication

Comparative Study Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

473-481

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR000062
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA077598
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA180880
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA007097
Pays : United States
Organisme : NCI NIH HHS
ID : U19 CA157345
Pays : United States

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved.For permissions, please e-mail: journals.permissions@oup.com.

Références

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3143-95
pubmed: 19959672
Tob Control. 2003 Dec;12(4):360-7
pubmed: 14660767
Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2035-42
pubmed: 15598758
Regul Toxicol Pharmacol. 2013 Jun;66(1):1-5
pubmed: 23454227
J Pharmacol Exp Ther. 2011 Jul;338(1):353-61
pubmed: 21515812
Mol Nutr Food Res. 2012 Dec;56(12):1825-37
pubmed: 23109489
Addiction. 2003 Sep;98(9):1191-5
pubmed: 12930202
Carcinogenesis. 2014 Nov;35(11):2526-33
pubmed: 25233931
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Mar 15;953-954:126-31
pubmed: 24608133
Tob Control. 2016 Jul;25(4):386-92
pubmed: 24570100
Chem Res Toxicol. 2013 Aug 19;26(8):1209-17
pubmed: 23837805
BMC Public Health. 2015 Mar 18;15:258
pubmed: 25849604
JAMA. 2018 Sep 4;320(9):880-891
pubmed: 30193275
Regul Toxicol Pharmacol. 2007 Mar;47(2):171-83
pubmed: 17034917
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Dec 15;1007:121-6
pubmed: 26595795
Chem Res Toxicol. 2010 Jun 21;23(6):1001-8
pubmed: 20408564
Psychol Aging. 1997 Jun;12(2):277-87
pubmed: 9189988
Chem Res Toxicol. 2009 Apr;22(4):734-41
pubmed: 19317515
Tob Control. 2016 May;25(3):267-74
pubmed: 25991608
Open Heart. 2018 Oct 8;5(2):e000846
pubmed: 30364426
Br J Addict. 1991 Sep;86(9):1119-27
pubmed: 1932883
Tob Control. 2003 Dec;12(4):349-59
pubmed: 14660766
Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):91-100
pubmed: 21068204
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Sep 15;935:36-40
pubmed: 23934173
Anal Bioanal Chem. 2015 Jul;407(18):5463-76
pubmed: 25935678
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Sep 15;857(1):1-8
pubmed: 17644451
Nicotine Tob Res. 2010 Feb;12(2):179-83
pubmed: 20064899
Inhal Toxicol. 2006 Sep;18(10):831-9
pubmed: 16774873
Nicotine Tob Res. 2010 Feb;12(2):105-16
pubmed: 20026503

Auteurs

Ellen Meier (E)

Department of Psychology, University of Wisconsin-Stevens Point, WI.

Bruce R Lindgren (BR)

Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN.

Amanda Anderson (A)

Department of Psychiatry, University of Minnesota, Minneapolis, MN.

Sarah A Reisinger (SA)

College of Medicine, Ohio State University, Columbus, OH.

Kaila J Norton (KJ)

Roswell Park Comprehensive Cancer Center, Buffalo, NY.

Joni Jensen (J)

Department of Psychiatry, University of Minnesota, Minneapolis, MN.

Lori Strayer (L)

Department of Psychiatry, University of Minnesota, Minneapolis, MN.

Laura Dick (L)

Department of Psychiatry, University of Minnesota, Minneapolis, MN.

Mei-Kuen Tang (MK)

Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN.

Menglan Chen (M)

Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN.

Steven G Carmella (SG)

Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN.

Stephen S Hecht (SS)

Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN.
Department of Psychiatry, University of Minnesota, Minneapolis, MN.

Sharon E Murphy (SE)

Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN.
Department of Psychiatry, University of Minnesota, Minneapolis, MN.

Jing Yang (J)

Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN.

Irina Stepanov (I)

Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN.
Department of Psychiatry, University of Minnesota, Minneapolis, MN.

Richard J O'Connor (RJ)

Roswell Park Comprehensive Cancer Center, Buffalo, NY.

Peter G Shields (PG)

College of Medicine, Ohio State University, Columbus, OH.

Dorothy K Hatsukami (DK)

Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN.
Department of Psychiatry, University of Minnesota, Minneapolis, MN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH